"We are entering this next stage as our FDA-cleared portfolio continues to expand to support broader cardiac imaging workflows,” said Davidi Vortman, the company's CEO and co-founder.
Israeli-led firm developing AI-guided cardiac sonography raises $24 million to expand in US market
